Position in EWTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,631,510
+$520,374 QoQ
Shares Held
83,540
-1.8% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 20.764903040459657.ToString("F0")%
Shared 0.ToString("F0")%
None 79.23509695954034.ToString("F0")%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,262,141 across 282 Biotechnology names. EWTX ranks #71 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in EWTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,631,510 | 83,540 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,111,136 | 85,075 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,700,326 | 104,829 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,474,652 | 112,483 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,394,414 | 108,837 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,733,999 | 102,397 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,692,273 | 100,872 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,769,824 | 98,269 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,536,318 | 84,228 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $703,803 | 64,333 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $364,485 | 63,610 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $490,420 | 63,280 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $389,067 | 58,331 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $455,850 | 50,990 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $434,386 | 44,145 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $332,043 | 41,714 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $357,551 | 36,861 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $466,208 | 30,511 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||